4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride
- CAS No.
- 388575-52-8
- Chemical Name:
- 4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride
- Synonyms
- PSN375963;PSN 375963 hydrochloride;PSN 375963, 10 mM in DMSO;5-(4-butylcyclohexyl)-3-pyridin-4-yl-1,2,4-oxadiazole;4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridine;Pyridine, 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-;4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride;Inhibitor,inhibit,PSN375963,receptor,PSN 375963,PSN-375963,G Protein-Coupled Receptor 119,endogenous,GPR119,ligand,orphan,cAMP
- CBNumber:
- CB12518900
- Molecular Formula:
- C17H23N3O
- Molecular Weight:
- 285.38
- MDL Number:
- MFCD01829706
- MOL File:
- 388575-52-8.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| PSN-375963 ≥98% (HPLC) | P0028 | 25mg | $358 |
| PSN375963 ≥98% | 10008593 | 1mg | $20 |
| PSN375963 ≥98% | 10008593 | 5mg | $81 |
| PSN375963 ≥98% | 10008593 | 10mg | $142 |
| PSN375963 ≥98% | 10008593 | 25mg | $306 |
| More product size | |||
| Boiling point | 440.1±47.0 °C(Predicted) |
|---|---|
| Density | 1.060±0.06 g/cm3(Predicted) |
| storage temp. | -20°C |
| solubility | DMSO: >10mg/mL |
| form | powder |
| pka | 0.82±0.10(Predicted) |
| color | white to off-white |
| InChI | 1S/C17H23N3O/c1-2-3-4-13-5-7-15(8-6-13)17-19-16(20-21-17)14-9-11-18-12-10-14/h9-13,15H,2-8H2,1H3 |
| InChIKey | OAVLEYPTWABFLF-UHFFFAOYSA-N |
| SMILES | CCCCC1CCC(CC1)c2nc(no2)-c3ccncc3 |
| FDA UNII | C9M28M425E |
| UNSPSC Code | 12352202 |
| NACRES | NA.77 |
4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride price More Price(41)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | P0028 | PSN-375963 ≥98% (HPLC) | 388575-52-8 | 25mg | $358 | 2022-05-15 | Buy |
| Cayman Chemical | 10008593 | PSN375963 ≥98% | 388575-52-8 | 1mg | $20 | 2026-04-30 | Buy |
| Cayman Chemical | 10008593 | PSN375963 ≥98% | 388575-52-8 | 5mg | $81 | 2026-04-30 | Buy |
| Cayman Chemical | 10008593 | PSN375963 ≥98% | 388575-52-8 | 10mg | $142 | 2026-04-30 | Buy |
| Cayman Chemical | 10008593 | PSN375963 ≥98% | 388575-52-8 | 25mg | $306 | 2026-04-30 | Buy |
4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride Chemical Properties,Uses,Production
Uses
PSN 375963 is a potent GPR119 agonist, with EC50s of 8.4 and 7.9 μM for human and mouse GPR119, respectively. PSN 375963 shows similar potency to the endogenous agonist oleoylethanolamide (OEA)[1][2].
Biochem/physiol Actions
PSN-375963 is a GPR119 partial agonist. GPR119 is an orphan GPCR, expressed predominantly in pancreas and GI tract, that has been characterized. Its endogenous ligands are oleoylethanolamide (OEA) and oleoyl-lysophosphatidylcholine, lipid signaling molecules that regulate food intake and body weight. OEA decreases food intake, so GPR119 agonists are potential therapies for obesity. Initial studies showed that PSN-375963 has similar potency and partial efficacy compared to OEA. Further studies revealed that although OEA and PSN-375963 are GPR119 agonists, they have divergent effects on insulin secretion, calcium signaling, and cAMP production.
References
[1] Overton HA, et al. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 2006;3(3):167-175. DOI:10.1016/j.cmet.2006.02.004
[2] Ning Y, et al. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. Br J Pharmacol. 2008;155(7):1056-1065. DOI:10.1038/bjp.2008.337
4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| Aladdin Scientific | tp@aladdinsci.com | United States | 50108 | 58 | |
| Dalian Meilun Biotech Co., Ltd. | 0411-62910999 13889544652 | sales@meilune.com | China | 4766 | 58 |
| Sigma-Aldrich | 021-61415566 800-8193336 | orderCN@merckgroup.com | China | 51389 | 80 |
| Angel Pharmatech, Ltd. | 17317130613 | 3358272972@qq.com | China | 3307 | 58 |
| BOC Sciences | -- | info@bocsci.com | USA | 0 | 65 |
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 | sales@chemegen.com | China | 11123 | 58 |
| Nantong Feiyu Biological Technology CO.,LTD | 0513-68819626 15152877458 | feiyubio@163.com | China | 4807 | 58 |
| TargetMol Chemicals Inc. | 4008200310 15002144251 | marketing@tsbiochem.com | China | 24951 | 58 |
| Beijing Famozi Pharmaceutical Technology Co., Ltd | 15811073878 | 2559355526@qq.com | China | 9993 | 58 |
View Lastest Price from 4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-05-11 | PSN 375963
388575-52-8
|
$35.00-118.00 | 99.63% | 10g | TargetMol Chemicals Inc. |
-

- PSN 375963
388575-52-8
- $35.00-118.00
- 99.63%
- TargetMol Chemicals Inc.




